Section 1202 QSBS Through an MSO: OBBBA 2025 Update

TECHNICAL BRIEF · §1202 QSBS PLANNING

How a Management Services Organization structured as a domestic C corporation may be evaluated for potential §1202 treatment — including under the 2025 OBBBA amendments — and how M&A counsel, transaction tax partners, and family office advisors should diligence the position.

By Alex Jones, EA, CFP®, CLU®, ChFC®, CEPA, Founder & CEO, Guardian Tax Consultants®. Published April 23, 2026. Last reviewed: June 25, 2026.

Executive summary

Section 1202 may provide a significant federal capital-gain exclusion for certain noncorporate shareholders who dispose of qualified small business stock, subject to detailed statutory requirements, limitations, and transaction-specific analysis.

For some Management Services Organizations structured as domestic C corporations, §1202 may become a relevant planning overlay if the issuer-level requirements can be satisfied and preserved over time. It should not be treated as the core reason to implement an MSO, and it should not be presented as an automatic path to tax-free gain.

This brief is written for transaction tax partners, M&A counsel, PE deal teams, and family-office advisors who are diligencing a QSBS position or designing an MSO from inception with § 1202 in mind. We work through the statutory framework, the OBBBA amendments, the services-business trap of § 1202(e)(3), the PLR landscape that distinguishes “management” from “consulting,” the stacking-and-packing architecture used to multiply per-taxpayer caps, the § 1045 rollover companion strategy, complete-liquidation mechanics under § 331, and the documentation file that should exist before any of this is relied upon at exit.

What this brief does not say

• This brief does not say that every MSO qualifies for §1202.
• It does not say that an MSO serving a disqualified operating company automatically avoids the §1202(e)(3) services exclusion.
• It does not say that a management company can be labeled into QSBS eligibility.
• It does not provide a legal opinion, tax opinion, penalty-protection opinion, or transaction-specific reporting conclusion.
• It does not determine whether any particular taxpayer should claim a §1202 exclusion.

The only appropriate conclusion is that an MSO taxed as a domestic C corporation may, in the right facts and with ongoing documentation, create a framework in which §1202 can be evaluated by the client's independent advisors.

Section 1202 in plain English: the gain exclusion and its five gating tests

Under IRC § 1202(a), a non-corporate taxpayer that sells QSBS held for more than five years generally excludes gain from gross income, subject to a per-issuer cap defined at § 1202(b). For QSBS acquired after September 27, 2010 and before July 4, 2025, that exclusion is 100% of eligible gain, capped at the greater of $10 million or 10× the taxpayer’s aggregate adjusted basis in the stock of the issuer disposed of during the taxable year (§ 1202(b)(1)). For QSBS acquired on or after July 4, 2025, the OBBBA replaces those numbers with the new $15 million cap and introduces a tiered exclusion schedule discussed in the next section.

The gating tests sit principally in § 1202(c) (definition of QSBS), § 1202(d) (definition of qualified small business), and § 1202(e) (active business requirement). Five gating elements have to be satisfied at the issuer level, contemporaneously and across the holding period:

• Domestic C corporation status (§ 1202(c)(1)(A)). The issuer must be a domestic C corporation at the time of original issuance and during “substantially all” of the taxpayer’s holding period. LLCs, S corporations, and partnerships do not qualify; conversion to C-corp is an option, but the QSBS holding clock starts at the date of stock issuance after conversion.
• Original issuance to the taxpayer (§ 1202(c)(1)(B)). The stock must be acquired by the taxpayer at original issuance, directly or through an underwriter, in exchange for money, property (other than stock), or as compensation for services rendered to the corporation. Secondary-market purchases generally do not qualify (with limited carryover-basis exceptions under § 1202(h)).
• Gross-assets test (§ 1202(d)(1)). The corporation’s aggregate gross assets must not have exceeded $50 million (pre-OBBBA) or $75 million (post-OBBBA, for stock issued on or after July 4, 2025) at any time from August 10, 1993 through immediately after issuance. The test bites at issuance; post-issuance growth above the threshold does not retroactively disqualify the stock.
• Active business requirement (§ 1202(e)). At least 80% of the corporation’s assets (by value) must be used in the active conduct of one or more “qualified trades or businesses” throughout substantially all of the taxpayer’s holding period. Working-capital limits and passive-asset caps apply under § 1202(e)(6) and (e)(7).
• Holding period (§ 1202(a)). Five years was historically a cliff. OBBBA replaces it with a tiered schedule for post-July-4-2025 issuances.

The active-business test imports a separately enumerated list of disqualified activities at § 1202(e)(3), which is where most professional-services businesses run aground. We come back to this in detail.

OBBBA 2025: what changed and what survived

The One Big Beautiful Bill Act, enacted as Pub. L. No. 119–21, made the most substantial expansion of § 1202 since the 100% exclusion was made permanent in 2015. The relevant statutory amendments sit in OBBBA § 70431, which modifies § 1202(a), (b), and (d). Three changes are operative for stock issued on or after July 4, 2025 (the “applicable date”):

1. Tiered holding period at § 1202(a)(5). The historical five-year cliff is replaced by a phased schedule: 50% gain exclusion at three years, 75% at four years, and 100% at five years or more. Stock acquired before July 4, 2025 remains on the five-year cliff. A practical consequence: stockholders facing a sale at year three or four no longer have to rely on a § 1045 rollover to preserve any benefit; they get a partial exclusion outright.
2. Per-issuer exclusion cap raised to $15 million at § 1202(b)(1). The greater-of cap becomes $15 million (up from $10 million) or 10× basis. The $15 million figure is indexed for inflation starting in calendar year 2027. The 10×-basis side of the cap is unchanged in mechanism, but is now far more powerful in conjunction with the higher gross-assets ceiling.
3. Gross-assets ceiling raised to $75 million at § 1202(d)(1). The aggregate gross-assets test rises from $50 million to $75 million for post-applicable-date issuances, also indexed for inflation from 2027 forward. In combination with the 10×-basis cap, a single taxpayer who contributes $74.9 million of basis at issuance can theoretically support up to $749 million of excludable gain on that issuance.

One non-obvious wrinkle: any gain in excess of the exclusion for stock held at the three- or four-year tiers is taxed at the § 1202 alternative capital gains rate of 28% under § 1(h), not the standard 15%/20% long-term capital gains rates. The 28% rate applies to the non-excluded portion in the tiered window; advisors should model this carefully when comparing a three-year exit at 50% exclusion against waiting for the five-year cliff.

What survived intact: the qualified-trade-or-business definition at § 1202(e)(3) and its services exclusion; the active-business 80% test; the original-issuance requirement; the redemption anti-churning rules of § 1202(c)(3); the § 1045 rollover; and the state-conformity patchwork. California, for example, still does not conform to § 1202 at all, and several other states partially conform — a point worth flagging early in any diligence.

Why an MSO May Be Evaluated for QSBS Planning

The central architectural insight is that § 1202 qualification is issuer-centric. The active-business test of § 1202(e) and the qualified-trade-or-business carve-outs of § 1202(e)(3) are applied to the corporation whose stock is being sold, not to that corporation’s customers. An MSO that contracts to perform genuine operational functions — revenue cycle management, human resources, IT infrastructure, billing, facilities, licensing, compliance — can be analyzed for QSBS eligibility on its own facts, regardless of what its operating-company counterparty does for a living.

This matters because the disqualified-fields list at § 1202(e)(3) sweeps in most of the businesses that closely held wealth is built in: “health, law, engineering, architecture, accounting, actuarial science, performing arts, consulting, athletics, financial services, brokerage services,” and any trade or business whose principal asset “is the reputation or skill of one or more of its employees.” A medical practice cannot itself issue QSBS. A wealth-management firm cannot itself issue QSBS. A consulting LLC, even after C-corp conversion, cannot itself issue QSBS for any post-conversion issuance.

A management services corporation may be evaluated differently when it performs operational services rather than disqualified professional, advisory, brokerage, financial, or consulting services. Where the MSO sells operations to the opco — not advice, not professional judgment — the QSBS analysis runs on the MSO’s own facts. Five design elements make this defensible:

• Domestic C-corp at all relevant times. Articles, EIN, federal elections, and minute books should show continuous C-corp status. If a prior LLC or S-corp existed, the conversion documents and effective-date papers should be in the file.
• Contracts and invoices describe operational outputs, not advice. The Master Services Agreement should describe deliverables — billing volumes, system uptime, HR transactions, claims processed — rather than hours of consulting time. Invoices should tie to those outputs, ideally with service-level agreements.
• Marketing avoids the word “consulting.” § 1202(e)(3) lists “consulting” as a disqualified field. Website copy, capability decks, and proposals should describe the MSO as an operations company, not a consulting firm.
• Enterprise value sits in systems and people, not in any one principal. Org charts, payroll, proprietary software, written processes, and a deep administrative workforce show that the principal asset is the MSO’s infrastructure — not the reputation or skill of any individual owner. This is critical for the § 1202(e)(3)(A)(iii) tail-end clause that disqualifies businesses whose principal asset is owner reputation or skill.
• The opco does not bill patients or clients for MSO services. Where the opco operates in a disqualified field (medical, legal, financial), the MSO should not be billing in that capacity. Patient invoices belong to the medical group; MSO invoices belong to the MSO. Separation should be visible in books, banking, and contracts.

For a deeper treatment of how MSO management fees should be calculated to support both the deduction position at the opco and the active-business test at the MSO, see our companion brief on management-fee design.

The services-exclusion trap of § 1202(e)(3)

The line between “management services” (potentially eligible) and “consulting” (categorically disqualified under § 1202(e)(3)) is the single most diligence-intensive issue in MSO QSBS planning. There are no Treasury Regulations on point; advisors work from the statutory text, the legislative history, and a small set of Private Letter Rulings.

The statutory text disqualifies trades or businesses involving “the performance of services in the fields of health, law, engineering, architecture, accounting, actuarial science, performing arts, consulting, athletics, financial services, brokerage services, or any trade or business where the principal asset of such trade or business is the reputation or skill of 1 or more of its employees.” The category most likely to ensnare an MSO is “consulting,” with a secondary risk under the reputation-or-skill tail.

Several PLRs — nonprecedential, but instructive on the IRS’s analytical framework — give planners traction:

• PLR 202342014 confirms that incidental advisory services, when not separately billed, do not disqualify a business whose primary activity is operational delivery. This is the closest direct analog to the typical MSO fact pattern.
• PLR 202125004 and PLR 202352009 distinguish between service businesses (in which clients pay for advice) and operational companies (in which clients pay for outputs, systems, or deliverables). The IRS focuses on what the customer is actually buying.
• PLR 202114002 approved QSBS treatment for an insurance intermediary that performed administrative functions, concluding the activity was not “brokerage” in the § 1202(e)(3) sense because the company delivered processing and administration rather than personal brokerage advice.
• PLR 202144026 approved QSBS treatment for a software company that served the healthcare industry, on the reasoning that the issuer was selling software (an operational deliverable), not practicing medicine.

The throughline is consistent: the IRS asks what is being sold, how revenue is earned, and where enterprise value resides. An MSO that sells advice billed by the hour will look like consulting. An MSO that sells run-rate operational services billed against deliverables or volumes — with revenue tied to the systems and workforce that produce them — looks like operations.

Stacking and packing: multi-shareholder and multi-trust § 1202 architecture

The per-issuer exclusion cap of § 1202(b)(1) is applied at the taxpayer level, not at the issuer level. Every separate non-grantor taxpayer who holds QSBS of the same issuer has its own cap. Two planning techniques exploit this:

• Stacking distributes ownership of QSBS across multiple taxpayers — the founder, the founder’s spouse, and one or more non-grantor trusts established for the benefit of children or other family members. Each separate taxpayer receives its own per-issuer cap (greater of $15 million or 10× that taxpayer’s basis). For a family group with four taxpayers, the aggregate exclusion ceiling can run to $60 million on the standard cap alone, before the 10×-basis cap is layered on.
• Packing increases the per-taxpayer adjusted basis at original issuance so that the 10×-basis cap binds at a higher number. Cash contributions and property-for-stock contributions count toward basis; services contributions generally do not for purposes of the 10× cap. Property contributions should be supported by contemporaneous appraisals; the IRS will scrutinize basis claims on audit, and a thinly documented stepped-up basis position is the most common attack surface.

The two techniques may be evaluated together, but only when the trust, basis, valuation, timing, and transfer-tax facts support the position. Distributing stock across taxpayers (stacking) multiplies the cap; contributing substantial basis at issuance (packing) raises the cap each taxpayer faces. A four-taxpayer family group that contributes $6 million of aggregate basis at issuance can, post-OBBBA, support up to $120 million of excludable gain under purely illustrative assumptions.

Several mechanical constraints have to be respected for the architecture to survive scrutiny:

• Each non-grantor trust must be a separate taxpayer. Trusts that are grantor as to the same individual are aggregated with that grantor for § 1202 purposes; only non-grantor trusts (or grantor trusts treated as wholly owned by different deemed owners) get separate caps.
• Trust funding must occur before the QSBS holding clock matters. Stock contributed to a non-grantor trust by gift takes a carryover basis and a tacked holding period under § 1202(h)(2). The trust steps into the donor’s § 1202 position, including the original-issuance status. Selling QSBS to a related trust (rather than gifting) usually destroys QSBS status in the trust’s hands.
• Gift-tax and GST exposure has to be planned around the federal exemption. Contributing high-basis stock to multiple trusts can absorb meaningful exemption. Coordinate with the family’s overall estate plan.
• Step-transaction and substance-over-form risk should be evaluated. A pre-sale rush to fan stock out across trusts on the eve of a binding letter of intent looks materially different from a multi-year trust structure established at issuance. Earlier is better.

The OBBBA changes amplify both techniques. The $15 million standard cap (up from $10 million) raises every taxpayer’s floor by 50%. The $75 million gross-assets ceiling means that a single packing contribution at issuance can support much higher 10×-basis caps without disqualifying the issuance.

Section 1045 rollover: the <5-year companion strategy

Where a QSBS sale occurs before the five-year holding period is satisfied, IRC § 1045 allows the stockholder to defer (not exclude) the recognized gain by rolling proceeds into replacement QSBS within 60 days. The replacement QSBS inherits a tacked holding period for § 1202 purposes, so the original holding clock continues; the stockholder ends up positioned to claim § 1202 exclusion on the eventual sale of the replacement QSBS.

Three points are worth emphasizing for diligence:

• § 1045 requires more than six months of original holding before the disposition. A sale at year four with a § 1045 rollover into replacement QSBS that is then held to year five-plus can deliver the same 100% exclusion outcome as if the original stock had been held the full term.
• Post-OBBBA tiered exclusions reduce, but do not eliminate, the value of § 1045. A stockholder facing a year-three sale gets 50% exclusion under the tiered schedule; a § 1045 rollover preserves the option for 100% exclusion on the eventual disposition of replacement stock. The choice depends on liquidity needs, the available replacement-QSBS opportunity, and state-conformity considerations.
• Partnership-level § 1045 elections are available under Rev. Proc. 98-48 for QSBS held through a partnership, with the election made at the partnership level and flowing through to the partners.

Complete-liquidation mechanics: when the buyer wants assets

A meaningful share of middle-market M&A is structured as asset purchases rather than stock purchases — buyers want a step-up in basis under § 1060, they want to leave behind unknown liabilities, and they often want to acquire only a slice of the target’s business. Asset-deal architecture is normally inconsistent with QSBS, because the gain on the asset sale is recognized at the corporate level and the subsequent shareholder distribution typically gets dividend treatment.

Section 331 provides a structuring alternative. Under § 331(a), amounts received by a shareholder in a complete liquidation of a corporation are treated as full payment in exchange for the stock. The distribution is therefore not a § 316 dividend; it is sale-or-exchange treatment, which is exactly what § 1202 requires under its “sale or exchange” language at § 1202(a)(1). Where the corporation has held QSBS-issuing status throughout and the shareholders have satisfied the five-year (or post-OBBBA tiered) holding period, the liquidation distribution can be eligible for § 1202 exclusion.

The Frost Brown Todd planning literature identifies three operative scenarios where complete liquidation under § 331 is the principal path to a § 1202-eligible exit:

• Buyer insists on an asset purchase. The corporation sells its assets, pays corporate-level tax on the asset gain, and then liquidates and distributes net proceeds. Shareholders treat the liquidating distribution as a stock sale; QSBS gain exclusion applies (subject to the per-issuer cap).
• Risk of statutory repeal or amendment. Where shareholders are concerned that § 1202 may be narrowed by a future Congress, triggering gain through a current liquidation locks in the exclusion under current law. This concern is materially reduced by the OBBBA expansion, but doesn’t disappear.
• Wind-down of a corporation whose business purpose is complete. Where the MSO has finished its useful life, complete liquidation converts the wind-down into a tax-efficient exit.

Procedurally, the corporation’s board should adopt a formal plan of dissolution and file IRS Form 966 within 30 days of the plan’s adoption, before any liquidating distributions are made. Where distributions are made over time (initial cash plus escrow, earn-out, holdback), formalizing the plan with Form 966 substantiates the § 331 exchange treatment for each tranche. Shareholders receiving installment obligations may report gain as collected under § 453(h) or elect out to accelerate the gain into the year of liquidation, allowing § 1202 exclusion to be claimed in full while the cap is binding.

Three traps to avoid: (i) ensuring that any distribution characterized as a declared dividend is excluded from the § 1202-eligible distribution amount — declared dividends taxed at capital-gain rates remain ineligible for § 1202; (ii) related-corporation redemptions that fall into § 304’s deemed-dividend zone; and (iii) the § 1202(c)(3) redemption-look-back rules, under which significant issuer redemptions within two years before or after original issuance can disqualify the issuance.

Reserved determination: qualification is tested again at exit

Any §1202 position should be treated as reserved until the relevant transaction occurs. Formation documents may establish the initial posture, but they do not conclusively determine the ultimate tax result.

At the time of sale, redemption, liquidation, recapitalization, rollover, or other transaction, the client's independent tax and legal advisors should re-evaluate whether the stock was QSBS at issuance, whether the issuer satisfied the active-business and qualified-trade-or-business requirements during substantially all of the holding period, whether any redemption or transfer activity created taint, whether state conformity affects the result, and whether the transaction produces sale-or-exchange treatment eligible for §1202 analysis.

Documentation: the QSBS file

Section 1202 positions are defended in audit on the strength of contemporaneous documentation. The QSBS file should exist at issuance and be updated quarterly. Minimum contents:

• Articles of incorporation, EIN documentation, federal C-corp election (where applicable), and corporate minute book reflecting continuous C-corp status.
• Stock ledger, subscription agreements, wire confirmations, and cap table at issuance, supporting the original-issuance requirement of § 1202(c)(1)(B).
• Balance sheet immediately before and after issuance, with use-of-proceeds schedule demonstrating the $75 million gross-assets ceiling of § 1202(d)(1) (or $50 million for pre-OBBBA issuances).
• Redemption analysis covering the two-year windows before and after issuance, with a “no-taint” memo or remediation file addressing any redemption activity that could implicate § 1202(c)(3).
• Qualified-trade-or-business narrative: Master Services Agreement and statements of work with the opco, sample invoices tied to deliverables, marketing screenshots avoiding consulting language, organizational chart, payroll register, and a description of proprietary systems and IP.
• Quarterly 80% active-business asset schedules, with each asset classified as “used in business” or otherwise, supported by a board-approved working-capital policy.
• Basis substantiation for each shareholder, including appraisals for any property-for-stock contributions relied on for the 10× cap.
• Trust instruments and gift documentation for any non-grantor trusts established as part of a stacking architecture.
• State-conformity memorandum tracking the treatment of § 1202 in each shareholder’s state of residence and at the issuer’s state of incorporation.
• Counsel memo on § 1202 posture, updated annually and pre-financing.

For an asset-sale-plus-liquidation exit, the file should also include the plan of dissolution, board resolutions, IRS Form 966, the asset purchase agreement, and any installment-obligation documentation.

Related provisions worth tracking

Several adjacent provisions interact with § 1202 in diligence-relevant ways:

• IRC § 1244 permits ordinary-loss treatment (up to $50,000/$100,000 joint) on the sale or worthlessness of stock in certain small business corporations. Where QSBS issuance is contemplated, § 1244 protection should also be designed in at the same time; the two provisions are not mutually exclusive.
• § 1202(f) addresses partnership ownership of QSBS, allowing a partner to claim § 1202 exclusion on the partnership’s sale of QSBS to the extent of the partner’s interest at the time the partnership acquired the stock.
• § 1202(h) contains the carryover-basis exceptions to the original-issuance requirement: gifts, transfers at death, and distributions from partnerships generally preserve QSBS status in the transferee’s hands.
• § 1202(i) addresses the basis rules for QSBS received in exchange for contributed property, an area particularly relevant to packing analysis.
• § 1202(k) grants Treasury authority to issue anti-abuse regulations. Few have been promulgated to date.
• § 304 can convert a related-party redemption into a deemed dividend, defeating § 1202 treatment.
• § 531 (accumulated earnings tax) is a separate compliance overlay for MSO C-corps that retain substantial cash. We address it separately in our brief on MSO cash uses and the § 531 documentation framework.

GTC's role in a §1202-positioned MSO

Guardian Tax Consultants® does not determine QSBS eligibility, issue legal opinions, prepare tax returns, or guarantee §1202 treatment. GTC's role is to help coordinate the MSO structure, documentation, governance cadence, management-fee support, active-business monitoring file, and advisor-facing diligence package.

Final legal conclusions, tax-return positions, opinion letters, transaction documents, and reporting decisions should be made by the client's independent legal counsel and tax advisors based on the facts and law applicable at the time of the relevant transaction.

Disclosures

This brief is general information for educational purposes. It is not legal or tax advice and does not establish an attorney-client or tax-advisor relationship. The IRC sections cited reflect the general legal framework as of the publication date; application is fact-specific and depends on issuer-level facts, issuance dates, holding periods, exclusions, redemptions, state conformity, and counsel review. Private Letter Rulings are nonprecedential under IRC § 6110(k)(3). Numbers in any illustration are placeholders for discussion and do not represent any client outcome. Readers should consult qualified counsel and tax advisors before acting.

Frequently asked questions

Can an LLC qualify for § 1202?

No. IRC § 1202(c)(1)(A) requires the issuer to be a domestic C corporation. LLCs and partnerships cannot issue QSBS directly. A pre-existing LLC may be converted to a C corporation, but the QSBS holding clock starts at the date of stock issuance after conversion; pre-conversion holding periods do not tack.

When did OBBBA § 70431 become effective?

The amendments to § 1202 are effective for stock acquired on or after July 4, 2025, the date of enactment of Pub. L. No. 119–21. Stock acquired before that date remains subject to the pre-OBBBA rules, including the $10 million per-issuer cap, the $50 million gross-assets ceiling, and the five-year holding cliff.

Does the § 1202(e)(3) services exclusion automatically disqualify an MSO?

Not necessarily. The exclusion sweeps in “consulting” and businesses whose principal asset is owner reputation or skill. An MSO that delivers operations — revenue cycle, HR, IT, billing — with contracts and invoices reflecting operational deliverables, and with enterprise value sitting in systems and a deep administrative workforce, is positioned outside the consulting category. PLR 202342014 and related rulings support this analytical framework. The MSO’s posture should be documented contemporaneously and confirmed by counsel.

Does the operating company’s field of business matter for the MSO’s QSBS analysis?

No. § 1202 qualification is tested at the issuer (the MSO), not at the issuer’s customers. An MSO that services a medical group, law firm, or financial-services platform may be evaluated for qualification on its own facts as a QSBS issuer if its own activities meet the qualified-trade-or-business test. This issuer-centric structure is the principal reason MSOs are used in § 1202 planning for disqualified-field opcos.

How does stacking multiply the exclusion?

The per-issuer cap of § 1202(b)(1) is applied at the taxpayer level. Each non-grantor taxpayer that owns QSBS — the founder, the founder’s spouse, separate non-grantor trusts — has its own cap. Distributing ownership across multiple taxpayers multiplies the aggregate exclusion ceiling. Trust independence, gift-tax exposure, and step-transaction risk must be diligenced.

What is packing?

Packing means increasing the per-taxpayer adjusted basis at original issuance so that the 10×-basis side of the § 1202(b)(1) cap binds at a higher number. Cash and property contributions count; services contributions generally do not. Post-OBBBA, with a $75 million gross-assets ceiling, packing is materially more powerful than before.

What is the § 1045 rollover?

IRC § 1045 permits a stockholder who sells QSBS held more than six months but less than five years to defer gain by rolling proceeds into replacement QSBS within 60 days. The replacement stock inherits a tacked § 1202 holding period, preserving the path to full exclusion at the eventual sale of the replacement.

How does § 1202 interact with an asset sale?

An asset sale at the corporate level triggers corporate-level tax and ordinarily produces dividend treatment on a subsequent shareholder distribution, defeating § 1202. The structuring alternative is to combine the asset sale with a complete liquidation under § 331(a), which characterizes the liquidating distribution as a sale or exchange of stock. With the QSBS requirements otherwise satisfied, the shareholders may be positioned to evaluate whether they can claim § 1202 exclusion on the gain.

What is the QSBS file?

The QSBS file is the contemporaneous documentation set supporting the § 1202 position: stock issuance and cap table, gross-assets schedule, qualified-trade-or-business narrative with MSAs and invoices, quarterly 80% active-business asset schedules, basis substantiation, redemption no-taint memo, trust instruments for any stacking architecture, state-conformity memorandum, and counsel opinion. It should be assembled at issuance and updated quarterly.

Do states conform to § 1202?

State treatment varies. California has historically not conformed to § 1202 at all; certain other states partially conform. State residency at the time of sale — for both the shareholder and any non-grantor trust — is a planning variable. Diligence should include a state-conformity memorandum.

What is the risk of QSBS “taint” from redemptions?

§ 1202(c)(3) disqualifies stock from QSBS status where the corporation engaged in significant redemptions from the taxpayer or related persons within the two-year window before or after issuance. A redemption analysis covering this window should be part of every QSBS file, with a written no-taint memorandum or remediation plan.

How does § 1244 fit in?

IRC § 1244 permits ordinary-loss treatment on the sale or worthlessness of stock in certain small business corporations, up to $50,000 per year ($100,000 joint). The provision is independent of § 1202 and runs in the other direction — it protects against loss rather than excluding gain — but is worth structuring in at issuance, since both provisions favor early documentation.